Proactive - Interviews for investors

Proactive - Interviews for investors

Download on the App Store

Proactive - Interviews for investors episodes

  • Bellevue Healthcare Trust on "the worst relative performance for healthcare in 30 years"
    Bellevue Healthcare Trust PLC (LSE:BBH) co-portfolio manager Paul Major visits the Proactive London studio to speak with Thomas Warner about what he calls "the strangest year" in his career and "the worst relative performance for healthcare in 30 years."
    He attributes the relatively poor performance of the sector to a series of negative macroeconomic and geopolitical events, including the collapse of Silicon Valley Bank, fluctuations in interest rates, and market overreaction to the advent of both AI and GLP-1 obesity drugs.
    He believes the healthcare sector offers attractive growth at lower valuations compared to other markets, driven by consistent demand due to the inevitability of health issues.
    The interview also delved into the broader implications of healthcare investments in an uncertain economic climate. Major positions healthcare is a defensive and intelligent choice, offering long-term growth regardless of economic conditions.
    He also discusses the shift towards value-based care in the U.S., where healthcare providers are being incentivised to deliver positive patient outcomes, leading to more efficient resource allocation and better overall healthcare management.
    Overall, Major's perspective offers a hopeful outlook for the healthcare sector in 2024, emphasising its resilience and growth potential amidst economic uncertainties.
    #BellevueHealthcareTrust #HealthcareInvestment #HealthcareSector #PaulMajorInterview #EconomicAnalysis #InvestmentStrategies #HealthcareStocks #MarketTrends2023 #InvestorInsights #HealthcareTechnology #GlobalEconomy #StockMarketAnalysis #InvestmentOpportunities #HealthcareTrends #FinancialMarkets #EconomicOutlook #InvestmentAdvice #HealthcareFunding #EconomicImpact #PortfolioManagement
    #ProactiveInvestors #health #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    19 min
  • Neural Therapeutics CEO defines success and senses "a lot of momentum" behind psychedelics
    Neural Therapeutics Inc CEO Ian Campbell speaks to Thomas Warner from Proactive about his vision for revolutionising mental health treatment.
    The company is working to develop medicines from from the San Pedro plant, in a challenge to traditional pharmaceutical methods that typically isolate single compounds.
    Campbell, with a diverse background in physical sciences, biology, toxicology, and engineering, explains that he transitioned to this field driven by a desire to contribute positively to humanity. His journey reflects a commitment to lifelong education and a passion for impactful scientific innovation. The CEO's personal connection to mental health issues within his family further motivates his mission, receiving supportive feedback from his family on this career shift.
    Currently, the company is focused on advancing their treatment into human clinical trials, navigating regulatory challenges and exploring the potential of botanicals in pharmaceuticals.
    Campbell's goal is to fast-track the drug's development, backed by evidence of mescaline's efficacy in treating various mental ailments. He says success for him would be "our product being delivered to humans."
    #NeuralTherapeutics #IanCampbell #MentalHealthInnovation #MescalineResearch #NaturalMedicine #Psychotherapy #MentalHealthAwareness #PharmaceuticalInnovation #HolisticHealth #SanPedroPlant #MentalWellness #ClinicalTrials #HealthcareLeadership #Biotechnology #MentalHealthAdvocacy #HealingJourney #ScienceAndWellness #TherapeuticBreakthrough #MentalHealthTreatment #HealthcareInnovation
    #ProactiveInvestors #psychedelics #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    10 min
  • FTSE 100 up, Nasdaq executive issues warning — Market Report
    Good morning from London where the FTSE 100 is marginally up from Friday’s close after a positive start for the miners as well as Vodafone and Entain.
    Vodafone is the big gainer on talk of spinning out its Italian operations in a deal with Paris-based Iliad worth €6.6bn upfront.
    And in the latest instalment of the transatlantic stock market soap opera, Nasdaq’s head of listings Karen Snow has been on Radio 4 this morning saying that she ‘absolutely’ believes more British companies will be IPO-ing across the pond since there’s a lot more money available over there.
    And some fresh figures from a body called the High Pay Centre show that the extra cash is not a draw to companies but to their bosses as well – S&P500 CEOs are typically paid 272 times more than their average employee while that figure is just 57 times the average here in the UK.
    Elsewhere on the FTSE and Games Workshop has sealed a deal with Amazon to create a series based on science-fiction fantasy miniature war game Warhammer. The agreement comes a year after the company first announced talks were taking place.
    Plenty still to come today including interviews with some big names in the small cap space – so stay tuned and have a great start to the week.
    #ProactiveInvestors #FTSE100 #nasdaq #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #news
    2 min
  • Aruma Resources welcomes highest REE grades yet at Saltwater
    Aruma Resources Ltd (ASX:AAJ) MD Glenn Grayson tells Proactive ongoing sampling at its 100%-owned Saltwater Project in Western Australia’s Pilbara region has returned the highest grade rare earth element (REE) results from the project to date. Recent surface rock sampling has identified high REE pathfinder elements and elevated TREO (total rare earth oxide) with surface rock sampling returning up to 1,777.5ppm TREO, including 752.2ppm neodymium-praseodymium (NdPr), and 1025.7ppm TREO. The company’s soil sampling has also delivered, returning best results of 1,092.5ppm TREO, including 242.2ppm NdPr, and 572.0ppm TREO in two areas.
    #ProactiveInvestors #ArumaResources #ASX #RareEarthElements #NdPr #CriticalMinerals
    #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    3 min
  • Alligator Energy talks uranium scoping study and new ISR copper investment
    Alligator Energy Ltd (ASX:AGE, OTC:ALGEF) CEO Greg Hall tells Proactive the company is set to make key improvements to the Samphire Uranium Project’s economics following scoping study revisions . The updated scoping study promises robust project economics, low environmental impact and considerable optimisation opportunities. Alligator has also expanded its interest in energy minerals with a strategic investment in EnviroCopper Ltd (ECL), gaining exposure to the company’s South Australian in-situ recovery (ISR) copper project portfolio and experienced ISR team.
    #ProactiveInvestors #AlligatorEnergy #ASX #Energy #uranium #ISRcopper
    #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    6 min
  • Iondrive advancing PFS for sustainable battery recycling
    Iondrive Ltd (ASX:ION) subsidiary Iondrive Technologies interim CEO Ebbe Dommisse gives Proactive an update on the commercialisation of its exclusively licensed battery technologies. The company has engaged Rho Motion, a highly respected UK-based battery supply chain consulting firm, to assist with completing a pre-feasibility study (PFS) for its deep-eutectic solvent (DES) battery recycling technology. The PFS includes a technical review involving a rigorous gap analysis by engineering firm Lycopodium. This is focusing on DES process analysis, upstream feed material evaluation from an Australian supplier and investigating downstream eco-friendly waste treatment. Iondrive expects that the PFS, which is due to be completed in the first quarter of next year, will establish the optimum commercialisation path for its DES battery recycling technology.
    #ProactiveInvestors #IondriveLtd #ASX #BatteryRecycling #tech
    #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    7 min
  • Lightning Minerals maps out new year drilling at Dundas
    Lightning Minerals Ltd (ASX:L1M) CEO Alex Biggs tells Proactive the company has appointed Gyro Drilling Australia for an upcoming drill program targeting lithium at its Dundas South Project. Up to 7,500 metres of aircore drilling is set to commence next month, targeting high-priority lithium in soil anomalism up to 218ppm lithium on tenement E63/2000. The program will be testing for pegmatites and lithium mineralisation at identified soil anomalies around 8-kilometres east of Liontown Resources’ Buldania project.
    #ProactiveInvestors #LightningMinerals #ASX #CriticalMinerals #Lithium
    #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    4 min
  • SensOre to split tech and exploration businesses
    SensOre Ltd (ASX:S3N) CEO Richard Taylor discusses with Proactive a strategic division of its exploration and technology assets. The company is also proposing to rebrand as Premier1 Lithium Limited, emphasising its lithium and critical minerals exploration. S3N has entered an agreement with joint-venture partner Deutsche Rohstoff AG for the acquisition of the 70% interest in lithium assets that SensOre did not already own via a scrip deal.
    #ProactiveInvestors #SensOreLtd #ASX #CriticalMinerals #Lithium #tech
    #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    4 min
  • Voyageur Pharmaceuticals takes major step forward announcing International Expansion
    Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to discuss the recent announcement regarding its international expansion and third-party manufacturing for barium sulfate products in the radiology market marks a significant development for the company. Voyageur has signed its first distribution deal with an international company. This is a crucial step in expanding its reach beyond Canada and tapping into global healthcare markets. The company's ability to capitalize on Health Canada's recognition of its licensed products in various countries positions it well to navigate international healthcare systems and serve a broader clientele. Voyageur Pharmaceuticals is making progress in developing and testing five products, with the goal of a market rollout in 2024. This suggests that the company is actively working on bringing its products to market.
    Willis told Proactive the third-party manufacturing initiative is a precursor to the Francis Creek project, which is expected to significantly reduce production costs for barium sulfate. This cost reduction could enhance the company's competitiveness and profitability. The company is on track to conduct a bankable feasibility study for the Francis Creek project in early 2024. Such a study is crucial for assessing the project's viability and attracting potential investors.
    In summary, Voyageur Pharmaceuticals appears to be strategically expanding its presence in the international healthcare market, investing in cost reduction measures, and actively developing and testing new products. The company's partnership and valuation indicate a promising outlook for the future, and stakeholders may look forward to updates on its dynamic ventures in the coming year.
    #proactiveinvestors #voyageurpharmaceuticalsltd #tsxv #vm #vyyrf #ctscan #xray
    #HealthcareExpansion #RadiologyMarket #InternationalBusiness #MedicalInnovation #GlobalHealth #BariumSulfate #CEOInsights #HealthCanada #DistributionDeals #MedicalTechnology #FrancisCreekProject #2024Outlook #MedicalIndustryNews #InnovationInMedicine #BusinessDevelopment #ThirdPartyManufacturing #HealthcareSystems #MarketRollout #BankableFeasibilityStudy #MedicalResearch #CorporateAchievements #RingCageCarbon #DrugDevelopment #2024Prospects
    #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    4 min
  • Volt Resources CEO talks 2023 Achievements and Graphite Market Insights for Explosive Growth in 2024
    Volt Resources CEO Prashant Chintawar joined Steve Darling from Proactive to share news discussed the company's 2023 achievements and challenges in a recent interview. Notable highlights include progress in securing partnerships, manufacturing agreements, and customer relationships for their downstream business. The natural graphite anode plant in the US has a pipeline of over $100 million for non-diluted funding. Despite successful mining campaigns in Tanzania, financing for the Boonoo project remains a priority.
    Chintawar told Proactive the Zavalievsky graphite business in Ukraine resumed operations successfully, producing over 1500 pounds of graphite material. Chintawar emphasized the growth potential in transitioning from selling flake graphite to graphite anode powder, focusing on the electric vehicle market. The graphite market is experiencing a "perfect storm" with China halting graphite exports and the US seeking domestic sources. Volt, with its integrated operating mine, is well-positioned to benefit. The CEO expressed optimism for a bright future for graphite, especially in the context of the growing demand for electric vehicles. The interview concluded with discussions on the unique advantage of Volt's producing mine and prospects for an interesting 2024.
    #proactiveinvestors #voltresourceslimited #asx #vrc #mining #graphite
    #CEOInterview #GraphiteMarket #2023Achievements #ElectricVehicles #MiningIndustry #ResourceSector #BusinessUpdates #GlobalMarkets #InvestmentOpportunity #SustainableEnergy #GreenTech #GraphiteAnode #MiningProgress #2024Outlook #MarketInsights #EconomicTrends #StrategicPartnerships #RenewableEnergy #MiningOperations #IndustryLeadership #ResourceInvestment #InnovationInMining #EnvironmentalImpact #CorporateStrategies#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    6 min

About Proactive - Interviews for investors

From the publisher's feed

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage.

More shows like Proactive - Interviews for investors

Autoline Daily by Autoline

Autoline Daily

80 Listeners

ev.news by Martyn Lee

ev.news

470 Listeners